| pubmed-article:2042433 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2042433 | lifeskim:mentions | umls-concept:C0007097 | lld:lifeskim |
| pubmed-article:2042433 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:2042433 | lifeskim:mentions | umls-concept:C0006611 | lld:lifeskim |
| pubmed-article:2042433 | lifeskim:mentions | umls-concept:C0013687 | lld:lifeskim |
| pubmed-article:2042433 | lifeskim:mentions | umls-concept:C0440743 | lld:lifeskim |
| pubmed-article:2042433 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2042433 | pubmed:dateCreated | 1991-7-10 | lld:pubmed |
| pubmed-article:2042433 | pubmed:abstractText | A new monoclonal antibody (Calam 27) that reacts with a membrane antigen present on cells of epithelial origin, but not on cells of mesothelial origin, was investigated as a means of distinguishing between mesothelial cells and malignant cells in cytologic smears of serous effusions from patients with carcinoma. Immunofluorescence staining of cells in 151 effusions from 109 patients with different diseases showed a good correlation between the cytologic diagnosis on routine preparations and the staining with Calam 27. Calam 27 was also used to study the ploidy and cell cycle kinetics of carcinoma cells versus reactive mesothelial cells and normal cells by flow cytometry; these experiments confirmed that Calam 27 is not reactive with mesothelial cells. In conclusion, Calam 27 staining can help to confirm the cytodiagnoses in cases with carcinomatous effusions. | lld:pubmed |
| pubmed-article:2042433 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2042433 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2042433 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2042433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2042433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2042433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2042433 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2042433 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2042433 | pubmed:issn | 0001-5547 | lld:pubmed |
| pubmed-article:2042433 | pubmed:author | pubmed-author:SchneiderMM | lld:pubmed |
| pubmed-article:2042433 | pubmed:author | pubmed-author:FerruaBB | lld:pubmed |
| pubmed-article:2042433 | pubmed:author | pubmed-author:DuplayHH | lld:pubmed |
| pubmed-article:2042433 | pubmed:author | pubmed-author:GioanniJJ | lld:pubmed |
| pubmed-article:2042433 | pubmed:author | pubmed-author:MazeauCC | lld:pubmed |
| pubmed-article:2042433 | pubmed:author | pubmed-author:ZanghelliniEE | lld:pubmed |
| pubmed-article:2042433 | pubmed:author | pubmed-author:CaldaniCC | lld:pubmed |
| pubmed-article:2042433 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2042433 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:2042433 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2042433 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2042433 | pubmed:pagination | 315-9 | lld:pubmed |
| pubmed-article:2042433 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:meshHeading | pubmed-meshheading:2042433-... | lld:pubmed |
| pubmed-article:2042433 | pubmed:articleTitle | A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions. | lld:pubmed |
| pubmed-article:2042433 | pubmed:affiliation | Antoine Lacassagne Center, Nice, France. | lld:pubmed |
| pubmed-article:2042433 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2042433 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2042433 | lld:pubmed |
